-
1دورية أكاديمية
المؤلفون: Peña, M.Aff1, Aff2, Montané, C.Aff1, Aff2, Paviglianiti, A.Aff1, Aff2, Hurtado, L., González, S., Carro, I.Aff1, Aff2, Maluquer, C.Aff1, Aff2, Domingo-Domenech, E.Aff1, Aff2, Gonzalez-Barca, E.Aff1, Aff2, Aff3, Sureda, A.Aff1, Aff2, Aff3, Mussetti, A.Aff1, Aff2, IDs41409023020692_cor11
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 58(11):1282-1285
-
2دورية أكاديمية
المؤلفون: Horwitz, S., O'Connor, O.A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N.L., Christensen, J.H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W.S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P., Shustov, A., Hüttmann, A., Savage, K.J., Yuen, S., Zinzani, P.L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.
المصدر: In Annals of Oncology March 2022 33(3):288-298
-
3دورية أكاديمية
المؤلفون: Domingo-Domenech, E, Boumendil, A, Climent, F, Sengeloev, H, Wahlin, B, Wattad, W, Arat, M, Finel, H, Schapp, N, Ganser, A, Yeshurun, M, Pavone, V, Snowden, J, Finke, J, Montoto, S, Sureda, A, Dreger, P
المصدر: Bone marrow transplantation. 55(4):796-803
مصطلحات موضوعية: Medicin och hälsovetenskap
-
4دورية أكاديمية
المؤلفون: Domingo-Domenech, E.Aff1, Duarte, R. F., Boumedil, A., Onida, F., Gabriel, I., Finel, H., Arcese, W., Browne, P., Beelen, D., Kobbe, G., Veelken, H., Arranz, R., Greinix, H., Lenhoff, S., Poiré, X., Ribera, J. M., Thompson, J., Zuckerman, T., Mufti, G. J., Cortelezzi, A., Olavarria, E., Dreger, P., Sureda, A., Montoto, S.
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 56(6):1391-1401
-
5دورية أكاديمية
المؤلفون: Garcia-Sanz, R. *, Sureda, A., de la Cruz, F., Canales, M., Gonzalez, A.P., Pinana, J.L., Rodriguez, A., Gutierrez, A., Domingo-Domenech, E., Sanchez-Gonzalez, B., Rodriguez, G., Lopez, J., Moreno, M., Rodriguez-Salazar, M.J., Jimenez-Cabrera, S., Caballero, M.D., Martinez, C.
المصدر: In Annals of Oncology April 2019 30(4):612-620
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
المؤلفون: Marín, M., Gudiol, C., Ardanuy, C., Garcia-Vidal, C., Jimenez, L., Domingo-Domenech, E., Pérez, F.J., Carratalà, J.
المصدر: In Clinical Microbiology and Infection June 2015 21(6):583-590
-
8دورية أكاديمية
المؤلفون: Martínez, C., Jorge, A. S., Pereira, A., Moreno, M., Núñez, J., Gayoso, J., Gonzalez-Medina, J., Revilla, N., Sampol, A., Domingo-Domenech, E., de la Cruz, F., Morales, A., Rodriguez-Salazar, M. J., Valiente, S., Pérez-Ceballos, E., de Oteyza, J. Pérez, García-Sanz, R., on behalf of Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)
المصدر: Annals of Hematology. January 2017 96(1):9-16
-
9دورية أكاديمية
المؤلفون: Gudiol, C., Bodro, M., Simonetti, A., Tubau, F., González-Barca, E., Cisnal, M., Domingo-Domenech, E., Jiménez, L., Carratalà, J.
المصدر: In Clinical Microbiology and Infection May 2013 19(5):474-479
-
10
المؤلفون: Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M, Illidge, T
المصدر: Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2022, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2021, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002مصطلحات موضوعية: Brentuximab Vedotin, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, overall survival, Medizin, Ki-1 Antigen, Lymphoma, T-Cell, Peripheral, Hematology, frontline treatment, randomized clinical trial, Oncology, Vincristine, brentuximab vedotin, Antineoplastic Combined Chemotherapy Protocols, Humans, peripheral T-cell lymphoma, CHOP
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3bfa6d1173b5676a4c251f8a185f45
https://findresearcher.sdu.dk:8443/ws/files/199229320/1_s2.0_S0923753421048754_main.pdf